Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2021-01-05 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Reinstatement to Official Quotation 1 page 89.6KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the reinstatement to official quotation of Anteris Technologies Ltd following a suspension of trading. It mentions the lifting of suspension and references a prior announcement about a proposed capital package. The document is short (640 characters) and serves as a regulatory announcement rather than a detailed report or financial statement. It does not contain financial data or detailed report content, nor is it a certification or voting result. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance notices.
2021-01-05 English
Cleansing Statement 2 pages 202.3KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 6 January 2021 titled 'Cleansing Notice'. It details the issuance of 316,954 fully paid ordinary shares to institutional and sophisticated investors at a specified price, raising approximately $1.1 million before costs. The notice references compliance with sections of the Corporations Act 2001 (Cth), specifically section 708A(5)(e), which relates to the issuance of shares without disclosure under Part 6D.2 of the Corporations Act. The document is short (3051 characters) and focuses on the issuance of new shares and related legal compliance. There is no financial report, earnings data, or management discussion. This fits the definition of a Share Issue/Capital Change announcement, which covers new share issues and capital changes.
2021-01-05 English
Research and Development Advance 2 pages 165.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 4 January 2021 regarding Anteris Technologies Ltd receiving a $1,220,000 research and development advance. It details the terms of a short-term facility related to the R&D tax incentive refund. The content focuses on a financing update related to the company's R&D tax incentive advance, including interest rates, repayment terms, and security. There are no financial statements, quarterly or annual results, or detailed management discussion. The document is short (3188 characters) and is an announcement of a financing event rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2021-01-03 English
Anti-calcification Comparison Study 2 pages 101.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 19 May 2020 from Admedus Limited regarding the commencement of a preclinical study on anti-calcification properties of their proprietary tissue. It is a brief announcement about a scientific study initiation and does not contain financial data, regulatory certifications, voting results, or detailed financial reports. The document length is short (2461 characters) and it is clearly an announcement of a study commencement rather than a report or detailed filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial or governance filings. It is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2020-05-18 English
AGM CEO Presentation 36 pages 9.3MB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 15 May 2020, providing the Chief Executive Officer's address and presentation to the Annual General Meeting (AGM) of Admedus Limited. The content includes detailed presentation slides and commentary related to the AGM, such as company strategy, financial highlights, and product development updates. There is no indication that this is a full annual report or financial statement filing, nor is it a brief announcement or voting result. The document is clearly the presentation material shared at the AGM, matching the definition of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-05-14 English
Results of Meeting 3 pages 253.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 15 May 2020, titled 'RESULTS OF ANNUAL GENERAL MEETING'. It provides detailed voting results from the Annual General Meeting (AGM) held on that date, including proxy votes and poll outcomes for various resolutions. The content focuses exclusively on the announcement of voting results rather than the AGM materials or the full report. The document length is 3182 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2020-05-14 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.